WHO ICTRP trial
The gut microbiome: a new pathway to obesity prevention and metabolic health
ACTRN12618000432213 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not recruiting
Key facts
| Trial ID | ACTRN12618000432213 |
|---|---|
| Public title | The gut microbiome: a new pathway to obesity prevention and metabolic health |
| Scientific title | The gut microbiome: a new pathway to obesity prevention and metabolic health |
| Primary sponsor | Professor Bernhard Breier (Chair in Human Nutrition) |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not recruiting |
| Study type | Observational |
| Conditions | Obesity;Metabolic Health |
| Interventions | We will conduct a cross sectional study in 136 Pacific women (known high risk of obesity, 68% obesity) and 136 NZ European women (known moderate risk of obesity, 28% obesity). Women will be selected such that half in each group will have a… |
| Registration date | Mar 26, 2018 |
| Target size | 272 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: